Stocks to Watch Today, November 4: Several stocks are likely to remain in focus on Wednesday following key corporate announcements, Q2 FY27 earnings and business developments. Among the major companies reporting quarterly results, State Bank of India (SBI) and NSE are in the spotlight, with both reporting strong year-on-year growth in net profit.
Yatharth Hospitals and Northern Arc Capital also posted healthy profit growth, while KEC International and Evonile Pharma reported weaker performances. Apart from earnings, stocks such as Ambuja Cements, Waaree Energies, Tata Motors, Prestige Estates Projects and Alkem Laboratories may see action following expansion plans, manufacturing developments, acquisitions and management changes.
Stocks to Watch Today
Here’s the list of stocks to watch on November 4:
| Stocks in focus | Why in focus |
| NSE | Q2 net profit jumps 23% to Rs 2,578 crore |
| SBI | Q2 net profit rises 14% to Rs 23,038 crore |
| Yatharth Hospitals | Q2 profit increases 17.45% to Rs 48.45 crore |
| Zydus Wellness | Returns to profitability in Q2 |
| Evonile Pharma | Reports Rs 77.54 crore net loss in Q2 |
| Prestige Estates Projects | To acquire Gloind Vintage Infra for Rs 519 crore |
| KEC International | Q2 net profit plunges; revenue falls 10% |
| Northern Arc Capital | Q2 profit jumps 41% to Rs 129 crore |
| IDBI Bank | Two-day employees’ strike against stake sale ends |
| Indian Energy Exchange (IEX) | October electricity trade volume rises 16.5% |
| Waaree Energies | US subsidiary begins production at two solar module lines |
| Tata Motors | Combined entity with Iveco to become world’s fourth-largest CV maker |
| Ambuja Cements | Announces Rs 14,500 crore capacity expansion plan |
| Alkem Laboratories | Appoints Amrut Naik as CEO |
NSE (National Stock Exchange) reported a 23 per cent year-on-year increase in consolidated net profit to Rs 2,578 crore in Q2 FY27. Total income rose 9 per cent to Rs 4,554 crore.
Yatharth Hospitals reported a 17.45 per cent increase in consolidated net profit to Rs 48.45 crore in Q2. Revenue from operations rose to Rs 431.42 crore.
Company Returns to Profit
Zydus Wellness reported a consolidated net profit of Rs 5.1 crore in the September quarter, compared with a net loss of Rs 52.8 crore in the corresponding period last fiscal.
Reports Rs 77.54 Crore Loss
Acquires Gloind Vintage Infra
Prestige Estates Projects will acquire 100 per cent equity in Gloind Vintage Infra. The acquisition carries an enterprise value of Rs 519 crore.
KEC International reported a sharp decline in Q2 net profit to Rs 30 crore. Revenue also declined 10 per cent year-on-year to Rs 5,468 crore.
Northern Arc Capital reported a 41 per cent year-on-year increase in Q2 profit to Rs 129 crore. Total income rose to Rs 874 crore in the September quarter.
Employees’ Two-Day Strike Ends
IDBI Bank employees’ two-day strike against the proposed stake sale to Fairfax has ended. Unions will meet on November 10 to discuss next steps amid valuation concerns.
IEX
Electricity Trade Volume Grows 16.5%
Indian Energy Exchange recorded 16.5 per cent year-on-year growth in electricity trade volume to 13,092 MUs in October. Day-Ahead Market prices surged 149 per cent amid higher demand.
US Manufacturing Lines Begin Production
Waaree Solar Americas has commenced commercial production on two new solar module manufacturing lines at its facility in Brookshire, Texas.
Combined Entity to Become World’s Fourth-Largest CV Maker
Tata Motors and Italy-based Iveco announced that their combined enterprise will become the world’s fourth-largest commercial vehicle maker, with revenue of Rs 2.28 lakh crore.
Announces Rs 14,500 Crore Expansion
Ambuja Cements will invest Rs 14,500 crore to expand manufacturing capacity. It aims to achieve 149 MTPA capacity by FY29 and 155 MTPA by FY30.
Alkem Laboratories has appointed Amrut Naik as its Chief Executive Officer, effective November 11, 2026.
(Disclaimer: The above article is meant for informational purposes only, and should not be considered as any investment advice. ET NOW DIGITAL suggests its readers/audience to consult their financial advisors before making any money-related decisions.)

